EUCRU

Eucrates Biomedical Acquisition Corp. Unit
EUCRU

Delisted

EUCRU was delisted on the 26th of April, 2023.

Back to rankings

17 hedge funds and large institutions have $12.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$788K
2
+$26.4K
3
+$1K

Top Sellers

1
-$780K
2
-$115K
3
-$82.3K
4
SMA
Sage Mountain Advisors
Georgia
-$76.7K
5
SIA
Schechter Investment Advisors
Michigan
-$61K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.96M
2
$2.49M
3
$1.57M
4
$1.29M
5
$1M
6
$860K
7
$759K
8
$759K
9
$114K
10
$56K
11
$40K
12
$18K
13
$3.93K
14
$2K
15
$1K
16
–
17
–
18
–